1 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow GSK3772847: new trials by email Literature Review of GSK3772847 trials Research Report on GSK3772847
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Repeat Dose Study of GSK3772847 in Participants With Moderate to Severe Asthma With Allergic Fungal Airway Disease (AFAD) GSK3772847, Placebo - Asthma | Phase 2 | Terminated | GlaxoSmithKline | 17 | 2018-04-18 | 2020-10-23 |
| Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma GSK3772847, Placebo, Fluticasone propionate/salmeterol - Asthma | Phase 2 | Completed | GlaxoSmithKline | 165 | 2017-09-14 | 2020-03-02 |
Asthma (2)
GlaxoSmithKline (2)
Russia (2) · Australia (1) · Canada (1) · France (1) · Mexico (1) · Netherlands (1) · Ukraine (1) · United Kingdom (1) · United States (1)
2017 (2)